Stanford Center for Cardiovascular Technology
CCVT

Stanford Center for Cardiovascular Technology

The Stanford Center for Cardiovascular Technology (CCVT), formerly known as the Center for Research in Cardiovascular Interventions, is a core facility for development and testing of new diagnostic or therapeutic technologies in cardiovascular medicine. The Center's focuses include early-stage concepts for new cardiovascular technologies, providing a clearinghouse where these ideas can be refined and tested in preclinical models and clinical studies.

This Center was founded in 1994 as a resource for both scientific and technologic growth in the field of interventional cardiology. The key component of the Center has now expanded to a group of Stanford faculty in a broader field of cardiovascular medicine. The Center is also supported with the knowledge and expertise of innovators in other departments at Stanford, including Cardiovascular Surgery, Interventional Radiology, Department of Bioengineering, as well as other Stanford programs dealing with the business and economics of health care.

Using Intravascular Ultrasound (IVUS) and other advanced imaging techniques such as OCT, Magnetic Resonance and CT, Core Laboratory Services are provided for both US and international research studies and clinical trials. As part of the cardiovascular training program at Stanford, this clinical research unit, known as Cardiovascular Core Analysis Laboratory (CCAL), utilizes a number of fellows and post-doctorates who are eager to work on scientifically challenging projects. Research from the CCAL has led to over 480 peer-reviewed or invited articles.

Hot topics in Cardiovascular technology

BVSDrug-eluting bioresorbable vascular scaffolds provide support to the coronary arterial wall with well-controlled inhibition of neointima for a defined period after deployment, but are subsequently resorbed and then help in restoration of physiological vasomotion, adaptive shear stress, and even late luminal gain... Full Story »


DAPTMillions of patients worldwide undergo coronary stenting with drug-eluting stents (DES) each year. Although DES reduce the rate of revascularization as compared with bare-metal stents, DES require longer duration of dual antiplatelet therapy (DAPT: a P2Y12-receptor inhibitor combined with aspirin)... Full Story »

FFRCTFractional flow reserve derived from coronary computed tomography (FFR-CT) is a novel diagnostic technology originally developed at Stanford that enables a combined anatomic–physiologic assessment of coronary artery disease (CAD)... Full Story »


RDNRenal sympathetic denervation therapy (RDN) is the first catheter-based invasive treatment for patients with treatment-resistant hypertension. Initial clinical trial results were encouraging with substantial decrements of blood pressure. However... Full Story »
RoboticsA recent study of percutaneous robotically-enhanced coronary intervention demonstrated 95.2% lower radiation exposure to the operators at the interventional cockpit than at the procedure table.... Full Story »

TAVRTranscatheter aortic valve replacement (TAVR) is a minimally invasive surgical procedure for patients with symptomatic aortic stenosis who are considered at high risk for standard valve replacement surgery... Full Story »

message from the director of Stanford CCVT

PJFWelcome to CCVT, where innovation meets clinical evaluation…Various imaging technologies from inside blood vessels (IVUS, OCT, FFR), to within the heart chambers (TEE, ICE) to outside the body (CT, MRI, PET) are critically evaluated in our laboratory to assess effectiveness of new technologies to help patients with cardiovascular disease.

We have young cardiologists involved at our Center, and their research and education key to realizing new ways to treat heart disease. Shown on the left are several vignettes for technologies we have recently been involved with….

Giving

 

As this year comes to an end, I am hoping that you will help me in the donation to our program…I am dedicated to this educational process and I personally donate as well each year. Such a donation qualifies for a tax write off and Stanford will provide validation documents.

Thanks again for your help and wishing you and your family a Happy

New Year.

Sincerely,

Peter
______________________________
Peter J. Fitzgerald, MD, PhD
Professor of Medicine & Engineering
Director, Center for CV Technology
Stanford University Medical Center

 

Stanford Medicine Resources:

Footer Links: